Companies
Clever Leaves to wind down Portugal operations
The restructuring initiative is expected to save the company USD$7 million by the end of 2023.
Stephanie Price
January 25, 2023
The restructuring initiative is expected to save the company USD$7 million by the end of 2023.
The medical cannabis company intends to rival other countries such as Canada, Germany and Israel with its own supply of medical cannabis from Scotland.
The country has confirmed it intends to produce cannabis products domestically.
Flora Lab 4 is located in Colombia.
The site will be opened by UK cannabis company Eden Pharma.
Glass Pharms has announced a number of partners for its cannabis cultivation facility project.
The Arizona state University study found high levels of contaminants in cannabis products.
Akanada has signed an exclusive licensing agreement with the iconic US brand.
The licence will enable the company to manufacture finished dosage forms, dried flowers and APIs.
This is the company’s most important strategic move to date, according to CEO Avinoam Sapir
The suggestion was made during a debate on the legalisation of cannabis.
Israel-based Xinteza has unveiled it has developed a non-Cannabaceae source for cannabinoid biosynthesis in research led by professor Asaph Aharoni
Panaxia’s investment in the country is a “milestone” for Malta’s medical cannabis industry, says Minister for the Environment, Energy and Enterprise.
The research provides insight into how trichomes create high quantities of cannabinoids without the plant poisoning itself.
Richard Lewis has more than 38 years of glasshouse experience.
Apollon has reached an agreement to acquire Citiva Jamaica in a part-cash, part-shares transaction.
Meddcann was given authorisation just one week after the country approved the regulation of cannabis for therapeutic purposes.
“This partnership with Tilray Brands is a game-changer for HEXO,” said Charlie Bowman, CEO of HEXO Corp.
We won’t spam you